Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China

Contributed by: Business Wire

Logo

Images

Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China (Photo: Business Wire)

Business Wire embedded0

Tags

Research

Genetics

Clinical Trials

Biotechnology

Health

Pharmaceutical

General Health

Other Science

Science

Gritgen Therapeutics Co., Ltd.

More Like This

Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

PR Newswire associated0

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

PR Newswire associated0

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

PR Newswire associated0

GenSci Launches Global Innovation Hub in Shanghai

WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

PR Newswire associated0

A Decade of Cell & Gene Therapy Manufacturing and Major GMP Facility Expansion: Cellex's Track Record of Scalable Excellence

PR Newswire associated0

Ascend Completes GMP Certification for Quality Control Testing in Munich Facility